Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FR2MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,706
Award facts
- Contract value 100% obligated
- $27,705.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,705.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Kesimpta 20 mg/0.4 mL pen injectors. The contract, which is non-set-aside and competitively awarded, calls for delivery by May 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide.
Kesimpta is a monoclonal antibody used for the treatment of relapsing forms of multiple sclerosis and represents the type of specialty pharmaceutical product that AmerisourceBergen provides through its federal medical supply contracts. As the prime contractor on this delivery order and the parent IDC, AmerisourceBergen leverages its position as a major pharmaceutical distributor to fulfill critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA's Medical Supply Chain utilizes this contract vehicle to ensure reliable access to brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military readiness and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FR2MA?
SPE2DB25FR2MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FR2MA worth?
The government has obligated $27,706 on SPE2DB25FR2MA.
Is contract SPE2DB25FR2MA an order under another contract?
Yes. SPE2DB25FR2MA is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR2MA competed?
The extent of competition for SPE2DB25FR2MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award